Abstract
Objective To evaluate the efficacy of 89Sr in treatment of multiple bone metastases of breast and prostate cancer patients. Methods Seventy multiple bone metastases patients (30 females with breast cancer and 40 males with prostate cancer) were treated with 89Sr. The clinical effectiveness was assessed by Karnofsky performance score and whole body bone scanning data. Results The total pain relief rate was 79% in bone metastases of breast cancer and 85% in bone metastases of prostate cancer, respectively. There was no significant differences between the two groups (x2 = 0.78, P＞0.05 ). The Karnofsky score was significantly improved in both groups (t = 2.46, P＜0.05; t = 2.68, P＜0.05). The bone marrow depression and the damage of liver and kidney were not observed in the two groups. Conclusion The analgesic effect of 89Sr treatment was good, and the quality of life was improved in patients with multiple bone metastases breast or prostate cancer. Key words: Breast neoplasms; Prostate neoplasms; Neoplasm metastasis; Bone neoplasms; Strontium radioisotopes
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
